Evidence map›Paper›PMID 31989036›Full record

ArticleBioengineering & translational medicine2020

Injectable supramolecular polymer-nanoparticle hydrogels enhance human mesenchymal stem cell delivery.

Abigail K Grosskopf, Gillie A Roth, Anton A A Smith, Emily C Gale, Hector Lopez Hernandez, Eric A Appel

Open access · goldAbstract read
In one paragraph

Article in Bioengineering & translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 102 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Biomaterial-Based Therapeutic Delivery of Immune Cells.Advanced healthcare materials · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. ACS nano · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Abigail K GrosskopfDepartment of Chemical Engineering Stanford University Stanford California.ORCID https://orcid.org/0000-0002-0471-1825
Gillie A RothDepartment of Bioengineering Stanford University Stanford California.ORCID https://orcid.org/0000-0002-3451-3694
Anton A A SmithDepartment of Materials Science & Engineering Stanford University Stanford California.ORCID https://orcid.org/0000-0001-6728-5299
Emily C GaleDepartment of Biochemistry Stanford University Stanford California.ORCID https://orcid.org/0000-0002-6536-3027
Hector Lopez HernandezDepartment of Materials Science & Engineering Stanford University Stanford California.ORCID https://orcid.org/0000-0001-6018-9587
Eric A AppelDepartment of Materials Science & Engineering Stanford University Stanford California.ORCID https://orcid.org/0000-0002-2301-7126
Stanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stem cell therapies have emerged as promising treatments for injuries and diseases in regenerative medicine. Yet, delivering stem cells therapeutically can be complicated by invasive administration techniques, heterogeneity in the injection media, and/or poor cell retention at the injection site. Despite these issues, traditional administration protocols using bolus injections in a saline solution or surgical implants of cell-laden hydrogels have highlighted the promise of cell administration as a treatment strategy. To address these limitations, we have designed an injectable polymer-nanoparticle (PNP) hydrogel platform exploiting multivalent, noncovalent interactions between modified biopolymers and biodegradable nanoparticles for encapsulation and delivery of human mesenchymal stem cells (hMSCs). hMSC-based therapies have shown promise due to their broad differentiation capacities and production of therapeutic paracrine signaling molecules. In this work, the fundamental hydrogel mechanical properties that enhance hMSC delivery processes are elucidated using basic

Indexed as

cell deliveryhuman mesenchymal stem cellhydrogelinjectable

Identifiers

PMID31989036
PMCPMC6971438
OpenAlexW2979919874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.